Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: NutraGenics

This article was originally published in The Tan Sheet

Executive Summary

NutraGenics: Receives a $5 mil. "private placement" from a group of Asian investors in exchange for 1 mil. shares of restricted common stock, the Phoenix-based company announces. Proceeds will be used for the national launch of NutraGenics' first dietary supplement product during the first quarter of 1997. The product is derived from rice and has been shown in animal tests to "promote normal cardiovascular circulation by altering cholesterol metabolism and providing a high degree of anti-oxidation protection in the blood," NutraGenics claims...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086377

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel